Repository logo
 
Publication

Bacterial degradation of the veterinary antibiotic florfenicol

dc.contributor.authorCouto, Ana T.
dc.contributor.authorAmorim, Catarina L.
dc.contributor.authorCastro, Paula M. L.
dc.date.accessioned2024-01-08T11:03:49Z
dc.date.available2024-01-08T11:03:49Z
dc.date.issued2018-10
dc.description.abstractFlorfenicol (FF) is a synthetic antibiotic, widely used in veterinary medicine. It is one of the few approved antibiotics for use in aquaculture during both production and processing operations, mainly to prevent and treat bacterial diseases. Therefore, this antibiotic is inevitably presented in the effluents from fish farms and eventually directly discharged in surface waters. Removal of FF has been mainly reported using physical-chemical processes but reports on its removal by biological processes is scarce. Bioremediation has been considered the strategy of choice to reduce the risk of hazardous chemicals in the environment. Therefore, microorganisms able to tolerate and degrade FF could represent added value towards more efficient biological removal processes. The main aim of this study was to investigate FF degradation by the bacterial strain Labrys portucalensis F11, capable to degrade other pharmaceuticals.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.urihttp://hdl.handle.net/10400.14/43489
dc.language.isoengpt_PT
dc.peerreviewednopt_PT
dc.titleBacterial degradation of the veterinary antibiotic florfenicolpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceAveiro, Portugalpt_PT
oaire.citation.titleChemPor 2018 – 13th International Chemical and Biological Engineering Conferencept_PT
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
61142951.pdf
Size:
519.83 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: